Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (61)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Wilson, P. J.
Right arrow Articles by Haines, J. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wilson, P. J.
Right arrow Articles by Haines, J. L.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Molecular Genetics, Vol 5, 249-256, Copyright © 1996 by Oxford University Press

ARTICLES

Novel mutations detected in the TSC2 gene from both sporadic and familial TSC patients

PJ Wilson, V Ramesh, A Kristiansen, C Bove, S Jozwiak, DJ Kwiatkowski, MP Short and JL Haines
Molecular Neurogenetics Unit, MGH East, Charlestown, MA 02129, USA.

Tuberous sclerosis (TSC) is an autosomal dominant disorder characterized by hamartomas in one or more organs, including the brain, skin, heart and kidneys. Linkage studies have shown locus heterogeneity with one TSC gene mapped to chromosome 9q34 and a second to 16p13.3. The gene on 16p13.3, TSC2, has been cloned and shown to encode a 5.5 kb transcript that is widely expressed. To facilitate the search for mutations in the TSC2 gene product, tuberin, we have designed an RT-PCR- based assay system to scan the expressed coding region of the TSC2 gene in lymphoblasts. Using 34 overlapping PCR assays we performed single- strand conformation polymorphism analysis of DNA from 26 apparently sporadic TSC cases, two TSC families non-informative for linkage analysis and two confirmed chromosome 16-linked TSC families. Of the 60 chromosomes scanned, 14 showed abnormal SSCP mobility shifts. Using direct PCR sequencing we have identified five missense mutations, one 3 bp in-frame deletion and one 2 bp frameshift deletion, one nonsense mutation, one 29 bp tandem duplication and five silent nucleotide changes that are likely to be polymorphisms. There is no apparent clustering of mutations within TSC2. The diversity of mutation types argues that TSC2 may not act in a classic tumor suppressor fashion. In addition, we saw no specific correlation between the different mutations and clinical severity or expression. These data confirm that TSC2 is indeed the relevant gene, and that a substantial number of sporadic cases arise from mutations in the TSC2 gene.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J Child NeurolHome page
V. Wong
Study of the Relationship Between Tuberous Sclerosis Complex and Autistic Disorder
J Child Neurol, March 1, 2006; 21(3): 199 - 204.
[Abstract] [PDF]

Home page
 NeurologyHome page
P. B. Crino and E. P. Henske
New developments in the neurobiology of the tuberous sclerosis complex
Neurology, October 22, 1999; 53(7): 1384 - 1384.
[Abstract] [Full Text] [PDF]

Home page
 J. Med. Genet.Home page
M. van Slegtenhorst, S. Verhoef, A. Tempelaars, L. Bakker, Q. Wang, M. Wessels, R. Bakker, M. Nellist, D. Lindhout, D. Halley, et al.
Mutational spectrum of the TSC1 gene in a cohort of 225 tuberous sclerosis complex patients: no evidence for genotype-phenotype correlation
J. Med. Genet., April 1, 1999; 36(4): 285 - 289.
[Abstract] [Full Text]

Home page
 ThoraxHome page
S. Johnson
Rare diseases bullet  1: Lymphangioleiomyomatosis: clinical features, management and basic mechanisms
Thorax, March 1, 1999; 54(3): 254 - 264.
[Full Text]

Home page
 Proc. Natl. Acad. Sci. USAHome page
B. E. Clurman and P. Porter
New insights into the tumor suppression function of P27Kip1
PNAS, December 22, 1998; 95(26): 15158 - 15160.
[Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
T. Soucek, R. S. Yeung, and M. Hengstschlager
Inactivation of the cyclin-dependent kinase inhibitor p27 upon loss of the tuberous sclerosis complex gene-2
PNAS, December 22, 1998; 95(26): 15653 - 15658.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
T. Soucek, O. Pusch, R. Wienecke, J. E. DeClue, and M. Hengstschlager
Role of the Tuberous Sclerosis Gene-2 Product in Cell Cycle Control. LOSS OF THE TUBEROUS SCLEROSIS GENE-2 INDUCES QUIESCENT CELLS TO ENTER S PHASE
J. Biol. Chem., November 14, 1997; 272(46): 29301 - 29308.
[Abstract] [Full Text] [PDF]

Home page
 ScienceHome page
M. v. Slegtenhorst, R. d. Hoogt, C. Hermans, M. Nellist, B. Janssen, S. Verhoef, D. Lindhout, A. v. d. Ouweland, D. Halley, J. Young, et al.
Identification of the Tuberous Sclerosis Gene TSC1 on Chromosome 9q34
Science, August 8, 1997; 277(5327): 805 - 808.
[Abstract] [Full Text]

Home page
 J. Biol. Chem.Home page
G.-H. Xiao, F. Shoarinejad, F. Jin, E. A. Golemis, and R. S. Yeung
The Tuberous Sclerosis 2Gene Product, Tuberin, Functions as a Rab5 GTPase Activating Protein (GAP) in Modulating Endocytosis
J. Biol. Chem., March 7, 1997; 272(10): 6097 - 6100.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.